These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 2657281

  • 1. Zinc compounds as therapeutic agents in peptic ulcer.
    Baños JE, Bulbena O.
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():117-22. PubMed ID: 2657281
    [Abstract] [Full Text] [Related]

  • 2. Zinc compounds, a new treatment in peptic ulcer.
    Escolar G, Bulbena O.
    Drugs Exp Clin Res; 1989; 15(2):83-9. PubMed ID: 2661183
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Peptic ulcer diseases. Perspectives on pathophysiology and therapy.
    Soll AH.
    J Clin Gastroenterol; 1989; 11 Suppl 1():S1-5. PubMed ID: 2809134
    [Abstract] [Full Text] [Related]

  • 8. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Nov 15; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prostaglandin analogues in the treatment of peptic ulcer disease].
    Laursen LS, Havelund T, Lauritsen K, Madsen JR.
    Ugeskr Laeger; 1989 Jan 09; 151(2):74-8. PubMed ID: 2643240
    [Abstract] [Full Text] [Related]

  • 14. Role of protective drugs in the prevention of ulcer relapse.
    Ota S, Terano A.
    J Gastroenterol; 1994 Jul 09; 29 Suppl 7():139-40. PubMed ID: 7921147
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W.
    Z Gastroenterol; 1987 Sep 09; 25 Suppl 4():34-40. PubMed ID: 3687149
    [Abstract] [Full Text] [Related]

  • 18. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
    Parent K.
    Postgrad Med; 1994 Nov 01; 96(6):53-9. PubMed ID: 7971612
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.